Idea principal
Pooling before-and-after changes in people with type 2 diabetes, a ketogenic diet was followed by lower fasting glucose (down 1.29 mmol/L, 95% CI -1.78 to -0.79) and lower HbA1c (down 1.07, 95% CI -1.37 to -0.78). Without control groups in the pooled estimates, the abstract cannot separate the diet's effect from other changes over time.
Study design
Revisión de evidencia
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
The ketogenic diet, very low in carbohydrate, is widely accepted to help obese people lose weight, but there was little systematic evidence on blood sugar and blood fats in people with diabetes. The authors pooled studies to estimate what happens to glycemic control, lipids and body size when people with type 2 diabetes follow it.
Población y método
Systematic review and meta-analysis using random-effects or fixed-effects models to estimate the average difference before and after a ketogenic diet intervention, with 95% confidence intervals, in patients with type 2 diabetes. The abstract does not report the number of studies, the number of participants, the diet duration or the units for most outcomes.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Fasting blood glucose fell by 1.29 mmol/L on average (95% CI -1.78 to -0.79) and glycated hemoglobin A1c (HbA1c) by 1.07 (95% CI -1.37 to -0.78).
- 2Triglycerides fell by 0.72 (95% CI -1.01 to -0.43) and total cholesterol by 0.33 (95% CI -0.66 to -0.01). HDL cholesterol rose by 0.14 (95% CI 0.03-0.25).
- 3LDL cholesterol fell by 0.05, with a reported interval of -0.25 to -0.15 that does not enclose the estimate, so this result cannot be read reliably from the abstract.
- 4Body weight fell by 8.66 (95% CI -11.40 to -5.92), waist circumference by 9.17 (95% CI -10.67 to -7.66) and BMI by 3.13 (95% CI -3.31 to -2.95).
Límites e incertidumbre
- 1The analysis compares before with after, so regression to the mean, weight loss itself and other simultaneous changes are not separated from the diet.
- 2The abstract gives no study count, sample size, diet length or units for most results, so how robust and how long-lasting the changes were is unknown.
- 3The total cholesterol interval just reaches zero (-0.66 to -0.01), and the LDL interval looks like a reporting error.
- 4This reading is based on the abstract only.
Relevancia práctica
A ketogenic diet was associated with improved blood sugar, HbA1c, triglycerides and weight in people with type 2 diabetes in these pooled studies, but the abstract cannot show how long the effects last or how it compares with other diets. Diabetes medicines may need adjustment on a very low carbohydrate diet, so any change should be planned with a clinician.
Tus datos
If you and your clinician are following glucose, a CGM or fasting finger-stick on the same meter at the same time of day gives the cleanest comparison, and weight and waist measured the same way each week add context. Look at multi-week trends; HbA1c itself is a lab test repeated every few months.
Cómo interpretar la evidencia
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
At present, the beneficial effect of the ketogenic diet (KD) on weight loss in obese patients is generally recognized. However, a systematic research on the role of KD in the improvement of glycemic and lipid metabolism of patients with diabetes is still found scarce.
Methods
This meta-study employed the meta-analysis model of random effects or of fixed effects to analyze the average difference before and after KD and the corresponding 95% CI, thereby evaluating the effect of KD on T2DM.
Results
After KD intervention, in terms of glycemic control, the level of fasting blood glucose decreased by 1.29 mmol/L (95% CI: -1.78 to -0.79) on average, and glycated hemoglobin A1c by 1.07 (95% CI: -1.37 to -0.78). As for lipid metabolism, triglyceride was decreased by 0.72 (95% CI: -1.01 to -0.43) on average, total cholesterol by 0.33 (95% CI: -0.66 to -0.01), and low-density lipoprotein by 0.05 (95% CI: -0.25 to -0.15); yet, high-density lipoprotein increased by 0.14 (95% CI: 0.03-0.25). In addition, patients' weight decreased by 8.66 (95% CI: -11.40 to -5.92), waist circumference by 9.17 (95% CI: -10.67 to -7.66), and BMI by 3.13 (95% CI: -3.31 to -2.95).
Conclusion
KD not only has a therapeutic effect on glycemic and lipid control among patients with T2DM but also significantly contributes to their weight loss.
Fuentes y atribución
Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis.
Yuan X, Wang J, Yang S, Gao M, Cao L, Li X, Hong D, Tian S, Sun C.
Nutrition & diabetes · 2020-11-30
DOI: 10.1038/s41387-020-00142-z ↗PubMed · 33257645 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

